| A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects (NCT05099133) | LEO Pharma | 2021-11-03 |
| Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers (NCT05089279) | Chong Kun Dang Pharmaceutical | 2021-11-03 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis (NCT06035354) | Akeso | 2021-11-03 |
| Drug-drug Interaction Study of Digoxin and AT-527 (R07496998) (NCT05137626) | Atea Pharmaceuticals, Inc. | 2021-11-03 |
| A Research Study Looking at New Protein-based Tablets in Healthy Male Participants (NCT05129891) | Novo Nordisk A/S | 2021-11-03 |
| FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia (NCT04714372) | Masonic Cancer Center, University of Minnesota | 2021-11-03 |
| Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours (NCT05114668) | Kazia Therapeutics Limited | 2021-11-03 |
| A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors (NCT05142423) | Akeso | 2021-11-03 |
| Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers (NCT05099549) | NKGen Biotech, Inc. | 2021-11-03 |
| A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors (NCT05084859) | Biosplice Therapeutics, Inc. | 2021-11-03 |
| Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study (NCT04884971) | University of Minnesota | 2021-11-03 |
| A Phase 1 Study of TT-00920 in Healthy Subjects (NCT05355129) | TransThera Sciences (Nanjing), Inc. | 2021-11-03 |
| A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers (NCT05236998) | SK Chemicals Co., Ltd. | 2021-11-03 |
| SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma (NCT05093608) | H. Lee Moffitt Cancer Center and Research Institute | 2021-11-03 |
| A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors (NCT04984668) | Suzhou Kintor Pharmaceutical Inc, | 2021-11-02 |
| Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC (NCT05053737) | University of Colorado, Denver | 2021-11-02 |
| Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients Following Coronary Stent Implantation (NCT04327635) | Christopher J. McLeod | 2021-11-02 |
| A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women (NCT04902131) | Ferring Pharmaceuticals | 2021-11-02 |
| Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK (NCT05164393) | Coegin Pharma AB | 2021-11-02 |
| Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide (NCT05097716) | Pfizer | 2021-11-02 |
| Relative Bioavailability and Food Effect Following Single Oral Dose of Darigabat Tablet Formulations in Healthy Participants (NCT05123079) | Cerevel Therapeutics, LLC | 2021-11-02 |
| dENdritic Cell Therapy Combined With SURgEry in Mesothelioma (NCT05304208) | Erasmus Medical Center | 2021-11-02 |
| Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression (NCT05163041) | BicycleTx Limited | 2021-11-02 |
| First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia (NCT05374278) | David Wilson | 2021-11-02 |
| Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially (NCT04563377) | University of Oxford | 2021-11-01 |
| Comparative Study Between Caudal Epidural Block and Ultrasound Guided Transversus Abdominis Plane Block for Post Operative Analgesia in Children Undergoing Infraumblical Surgeries (NCT05117021) | Sohag University | 2021-11-01 |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors (NCT05187338) | Second Affiliated Hospital of Guangzhou Medical University | 2021-11-01 |
| Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML (NCT05334693) | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | 2021-11-01 |
| Testing a New Self-help Intervention for Infertility Related Distress: a Pilot Study (NCT05103982) | University of Regina | 2021-11-01 |
| A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers (NCT05069623) | Nykode Therapeutics ASA | 2021-11-01 |
| Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location (NCT04925583) | University Hospital Heidelberg | 2021-11-01 |
| Probiotics for Enhanced Tissue Carotenoid Status in Premenopausal Women (NCT04511052) | McGill University | 2021-11-01 |
| Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients (NCT05221775) | Tianjin Medical University Cancer Institute and Hospital | 2021-11-01 |
| The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications (NCT04435015) | Yale University | 2021-11-01 |
| Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea (NCT05616923) | Albany Research Institute, Inc. | 2021-11-01 |
| β-globin Restored Autologous HSC in β-thalassemia Major Patients (NCT04205435) | Bioray Laboratories | 2021-11-01 |
| Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized (NCT05016934) | Hospital do Coracao | 2021-11-01 |
| Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy (NCT05620004) | Sun Yat-sen University | 2021-11-01 |
| A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen (NCT05126316) | H. Lundbeck A/S | 2021-11-01 |
| Safety, Tolerability, and Pharmacokinetics of ASC43F, a Fixed Dose Combination Tablet in Healthy Subjects (NCT05118516) | Gannex Pharma Co., Ltd. | 2021-11-01 |
| RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors (NCT05122572) | Wuxi People's Hospital | 2021-11-01 |
| Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells (NCT05628545) | Guangdong GD Kongming Biotech LLC | 2021-11-01 |
| Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors (NCT05037149) | Sirnaomics | 2021-11-01 |
| Intralesional Vitamin D in Alopecia Areata (NCT04660786) | Alexandria University | 2021-11-01 |
| A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB (NCT04853823) | Hapten Sciences, Inc. | 2021-11-01 |
| CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer (NCT05122546) | City of Hope Medical Center | 2021-11-01 |
| Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2 (NCT05152914) | David L Rogers, MD | 2021-11-01 |
| A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors (NCT05136937) | Wuxi People's Hospital | 2021-11-01 |
| Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML (NCT05272293) | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | 2021-11-01 |
| Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (NCT04851301) | University of Maryland, Baltimore | 2021-11-01 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants (NCT05131971) | GlaxoSmithKline | 2021-11-01 |
| Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST) (NCT05080621) | Deciphera Pharmaceuticals, LLC | 2021-11-01 |
| A Comprehensive Analysis for Identification of Risk Factors for Running-Related Injuries (NCT04642248) | ACE Running LLC | 2021-11-01 |
| Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma (NCT05075681) | Chinese PLA General Hospital | 2021-11-01 |
| Tricaprilin Infantile Spasms Pilot Study (NCT04727970) | Cerecin | 2021-11-01 |
| GLS-5310 Vaccine in Healthy Volunteers for the Prevention of SARS-CoV-2 (COVID-19) (NCT05085639) | GeneOne Life Science, Inc. | 2021-11-01 |
| 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis (NCT05627778) | Peking Union Medical College Hospital | 2021-11-01 |
| Circulating Tumor DNA in Melanoma Patients (NCT07422805) | Institute of Oncology Ljubljana | 2021-11-01 |
| A Study of HS-20094 in Healthy Participants (NCT05116410) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-11-01 |
| A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis (NCT05107037) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-11-01 |
| Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study) (NCT04331288) | Pop Test Oncology LLC | 2021-11-01 |
| Daratumumab and Belatacept for Desensitization (NCT04827979) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-11-01 |
| Sentinel Node Localization and Staging with Low Dose Superparamagnetic Iron Oxide (NCT05359783) | Vastra Gotaland Region | 2021-11-01 |
| Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan (NCT05005403) | AbbVie | 2021-11-01 |
| HRV and Coaching Preparation Phase Study (NCT05150574) | Brock University | 2021-11-01 |
| First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine (NCT05104515) | Oxford Vacmedix UK Ltd. | 2021-11-01 |
| A Study to Compare PK, PD and Safety of the AD-214 and AD-2141 (NCT05062876) | Addpharma Inc. | 2021-11-01 |
| Effects of Inorganic Nitrate and Intensity of Exercise on Cardiovascular Health in Post-Menopausal Females (NCT05221905) | University of Virginia | 2021-11-01 |
| Evaluating the Benefits of Physiologic Insulin Delivery (NCT04416737) | Stanford University | 2021-11-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled HH-120 Aerosol in Healthy Volunteers (NCT05116865) | Huahui Health | 2021-11-01 |
| Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects (NCT05135871) | LianBio LLC | 2021-10-31 |
| Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State (NCT05098262) | Dong-A ST Co., Ltd. | 2021-10-31 |
| Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma (NCT05031949) | Zhang Bi Xiang, MD | 2021-10-30 |
| Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions (NCT05128175) | Shanghai WD Pharmaceutical Co., Ltd. | 2021-10-29 |
| Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients (NCT05073484) | Bio-Thera Solutions | 2021-10-29 |
| A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function (NCT05098054) | Takeda | 2021-10-29 |
| Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects (NCT05152420) | VarmX B.V. | 2021-10-29 |
| A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants (NCT05089019) | Loxo Oncology, Inc. | 2021-10-29 |
| A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (NCT05117476) | Cullinan Therapeutics Inc. | 2021-10-29 |
| Biotin-RBC Transfusion in SCD (NCT04426591) | Marianne Yee | 2021-10-29 |
| ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies (NCT05085548) | ProDa BioTech, LLC | 2021-10-29 |
| A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms (NCT04955938) | University of Chicago | 2021-10-29 |
| The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers (NCT05083468) | Shanghai SIMR Biotechnology Co., Ltd. | 2021-10-29 |
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test (NCT04958109) | Massachusetts General Hospital | 2021-10-28 |
| Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients (NCT05027269) | Avidity Biosciences, Inc. | 2021-10-28 |
| Study in ALS With Abatacept & IL-2 (NCT06307301) | The Methodist Hospital Research Institute | 2021-10-28 |
| A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression (NCT05196971) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-10-28 |
| Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State (NCT05108571) | Dong-A ST Co., Ltd. | 2021-10-28 |
| Airway Immune Response to Allergens (Use Lay Language Here) (NCT04619017) | JOSALYN CHO | 2021-10-28 |
| Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers (NCT05019950) | NImmune Biopharma | 2021-10-28 |
| A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects (NCT05137600) | Antios Therapeutics, Inc | 2021-10-28 |
| A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma (NCT05139225) | Memorial Sloan Kettering Cancer Center | 2021-10-28 |
| An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I) (NCT04453085) | JCR Pharmaceuticals Co., Ltd. | 2021-10-28 |
| Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP) (NCT04542382) | University of California, San Francisco | 2021-10-28 |
| A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers (NCT05023525) | Haisco Pharmaceutical Group Co., Ltd. | 2021-10-28 |
| Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects (NCT05226338) | InventisBio Co., Ltd | 2021-10-27 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9933 in Adult Healthy Volunteers (NCT05102136) | Regeneron Pharmaceuticals | 2021-10-27 |
| The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects (NCT05085197) | Staidson Biopharma Inc. | 2021-10-27 |
| A Phase Ia/Ib Clinical Trial of IBI360 Monotherapy or in Combination With Sintilimab and (or) Chemotherapy in Advanced or Metastatic Solid Tumors (NCT05043298) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-10-27 |
| Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease (NCT05121142) | Children's Hospital Medical Center, Cincinnati | 2021-10-27 |